Big pharma racing to hedge patent expiry
Pharma firms closed biopharma buyouts worth over a hundred billion dollars in the first half of the year, racing to replace top selling medicines worth around $400 billion before patents expire. Leah Bennett of…
Source: Reuters ↗ · 2026-10-05 · Official embed (owner allows embedding) · kind: news
Played through the owner's official player or file host; Banana News does not host or copy the video.
